Pharmaceutical industry is in an 'unprecedented race' for a COVID-19 vaccine: GeoVax CEO
In this article:
GeoVax Chairman & CEO David Dodd joins the On the Move panel to discuss the latest in the race for a COVID-19 vaccine.
Advertisement
Recommended Stories
Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Motley Fool•Trump to set interest rates himself under secret presidential plan
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The Telegraph•Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
The $50 million purchase could turn into Nvidia's biggest investment.
Motley Fool•Generative AI Software Sales Could Soar 6,260%: My Pick for the Best AI Stock to Buy Now (Hint: Not Nvidia)
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
Motley Fool•2 Incredibly Cheap Dividend Stocks to Buy Now
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
Motley Fool•2 Stock-Split Stocks to Buy Hand Over Fist Right Now
These proven wealth builders could be exactly what you're searching for right now.
Motley Fool•My late aunt gave her husband a life tenancy in her home — but her attorney won’t even let us see the will. Is this a bad sign?
“When she died, we were told by her attorney that we were responsible for the taxes and property insurance during the time when the life tennant lives in the home.”
MarketWatch•Want $1 Million In Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade.
These three tech stocks look like reliable long-term winners.
Motley Fool•In 4 Days, Philip Morris Stock Becomes an Even Better Investment
The tobacco giant will soon be allowed to sell a proven product in a proven market.
Motley Fool•Powell Is Poised to Keep Fed on Higher-for-Longer Path
(Bloomberg) -- Jerome Powell’s remarks in the coming week will be closely parsed by investors for any clues on just how long the Federal Reserve is willing to wait before cutting interest rates.Most Read from BloombergBHP’s $39 Billion Copper Play Was Years in the MakingApple Intensifies Talks With OpenAI for iPhone Generative AI FeaturesPlunging Home Prices, Fleeing Companies: Austin’s Glow Is FadingThe Long, Slow Death of Urban NightlifeWall Street Humbled as Fast-Reversing Markets Confound th
Bloomberg•